[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-349966-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-349966-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","all-cause-mortality-and-cancer-risk-dependent-on-blood-se-level-and-hrg-rs10770-genotypes-on-a-prospective-cohort-of-women-with-familial-breast-cancers","All-Cause Mortality and Cancer Risk Dependent on Blood Se Level and HRG rs10770 Genotypes on a Prospective Cohort of Women with Familial Breast Cancers","","This prospective cohort study examined whether HRG genotypes modify the relationship between selenium (Se) status and all-cause mortality and cancer risk in women from familial breast cancer families. The analysis included 2782 women aged 40+ registered at a hereditary cancer center, excluding BRCA1 carriers and previously diagnosed cancers. Blood Se was measured by inductively coupled plasma mass spectrometry, while HRG rs10770 genotypes were assessed using real-time PCR with TaqMan probes. After about 6 years follow-up, results showed HRG-dependent differences in mortality and cancer risk, with the strongest effects in women with low Se (Q1).",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/all-cause-mortality-and-cancer-risk-dependent-on-blood-se-level-and-hrg-rs10770-genotypes-on-a-prospective-cohort-of-women-with-familial-breast-cancers/349966/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/all-cause-mortality-and-cancer-risk-dependent-on-blood-se-level-and-hrg-rs10770-genotypes-on-a-prospective-cohort-of-women-with-familial-breast-cancers/349966.png","ImageObject",300,407,{"name":42,"@type":43},"Ophelia","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the main aim of the study?","Question",{"text":63,"@type":64},"To determine whether HRG genotypes modify the effect of selenium (Se) on all-cause mortality and cancer risk.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were selenium levels and HRG rs10770 genotypes measured?",{"text":68,"@type":64},"Blood Se levels were measured using inductively coupled plasma mass spectrometry, and HRG rs10770 genotypes were analyzed with real-time PCR using TaqMan probes.",{"name":70,"@type":61,"acceptedAnswer":71},"What key patterns were observed for mortality risk?",{"text":72,"@type":64},"Women with blood Se in the lowest quartile (Q1) showed higher all-cause mortality risk, with the effect being stronger in HRG non-TT carriers than in HRG TT carriers.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},349966,1790180648,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":127,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},7971461741311,"https://ap-avatar.wpscdn.com/avatar/74000253aff267980c6?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779345379180704826","Article  \nAll-Cause Mortality and Cancer Risk Dependent on Blood Se Level and HRG rs10770 Genotypes on a Prospective Cohort of Women with Familial Breast Cancers  \nKrzysztof Lubi ´nski 1, Adam Stachowski 1, Wojciech Marciniak 2, Róa Derkacz 2, Adam Kilja ´nczyk 1,2,3, Milena Kilja ´nczyk 1,2, Marcin R. Lener 1, Sandra Pietrzak 1, Cezary Cybulski 1,2, Tadeusz D˛ebniak 1, Tomasz Huzarski 1,2,4, Wojciech Klu´zniak 1,2, Tadeusz Sulikowski 5, Jan Lubi ´nski 1,2, Rodney J. Scott 6,7,8 and Jacek Gronwald 1,2, *  \nReceived: 27 December 2025  \nRevised: 21 February 2026  \nAccepted: 25 February 2026  \nPublished: 5 March 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, ul. Unii Lubelskiej 1, 71-252 Szczecin, Poland; [krzychul123456789@gmail.com](krzychul123456789@gmail.com) (K.L.); [adam.stachowski@pum.edu.pl](adam.stachowski@pum.edu.pl) (A.S.); [adam.kiljanczyk@pum.edu.pl](adam.kiljanczyk@pum.edu.pl) (A.K.);  \n[milena.matuszczak@pum.edu.pl](milena.matuszczak@pum.edu.pl) (M.K.); [marcinlener@poczta.onet.pl](marcinlener@poczta.onet.pl) (M.R.L.);  \n[sandra.pietrzak@pum.edu.pl](sandra.pietrzak@pum.edu.pl) (S.P.); [cezarycy@pum.edu.pl](cezarycy@pum.edu.pl) (C.C.); [debniak@pum.edu.pl](debniak@pum.edu.pl) (T.D.);  \n[huzarski@pum.edu.pl](huzarski@pum.edu.pl) (T.H.); [wojciech.kluzniak@pum.edu.pl](wojciech.kluzniak@pum.edu.pl) (W.K.); [lubinski@pum.edu.pl](lubinski@pum.edu.pl) (J.L.)  \n2 Read-Gene, Grzepnica, ul. Alabastrowa 8, Grzepnica, 72-003 Dobra (Szczeci ´nska), Poland; [wojciech.marciniak@read-gene.com](wojciech.marciniak@read-gene.com) (W.M.); [roza.derkacz@gmail.com](roza.derkacz@gmail.com) (R.D.)  \n3 Department of Diagnostic Imaging and Interventional Radiology, Pomeranian Medical University Hospital No 1, 70-204 Szczecin, Poland  \n4 Department of Clinical Genetics and Pathology, University of Zielona Góra, ul. Zyty 28, 65-046 Zielona Góra, Poland  \n5 Department of General, Minimally Invasive, and Gastroenterological Surgery, Pomeranian Medical University in Szczecin, 71-252 Szczecin, Poland; [tadeusz.sulikowski@pum.edu.pl](tadeusz.sulikowski@pum.edu.pl)  \n6 Priority Research Centre for Cancer Research, Innovation and Translation, Hunter Medical Research Institute, New Lambton Heights, NSW 2308, Australia; [rodney.scott@newcastle.edu.au](rodney.scott@newcastle.edu.au)  \n7 School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW 2308, Australia  \n8 Division of Molecular Medicine, Pathology North, John Hunter Hospital, New Lambton, NSW 2305, Australia  \n* [Correspondence: jgron@pum.edu.pl](Correspondence: jgron@pum.edu.pl)  \nAbstract  \nThe aim of this study was to investigate whether genotypes of HRG may modify the effect of Se(selenium) on all-cause mortality and cancer risk. The study was conducted on 2782 initially unaffected women from families with familial breast cancers, all registered atthe Hereditary Cancer Centre in Szczecin. Participants were aged 40 years or older and were recruited between September 2010 and March 2024 . Women carrying a BRCA1 mutation and those with a diagnosed cancer were excluded from the study. Blood Se levels were measured using inductively coupled plasma mass spectrometry, and molecular analyses of HRG (Histidine-rich glycoprotein) genotypes were performed using real-time PCR with TaqMan probes. After an average follow-up period of 6 years and 2 months, 89 deaths and 210 cases of cancer were identified. The study showed significant differences in the reference range of blood selenium levels, as well as its impact on all-cause mortality and cancer risk, depending on HRG genotype. The most striking finding regarding all-cause mortality risk was observed among women","cbCairPM94gLa7SX","https://ap.wps.com/l/cbCairPM94gLa7SX","pdf",747766,"English","# Abstract\n# Introduction","[{\"question\":\"What was the main aim of the study?\",\"answer\":\"To determine whether HRG genotypes modify the effect of selenium (Se) on all-cause mortality and cancer risk.\"},{\"question\":\"How were selenium levels and HRG rs10770 genotypes measured?\",\"answer\":\"Blood Se levels were measured using inductively coupled plasma mass spectrometry, and HRG rs10770 genotypes were analyzed with real-time PCR using TaqMan probes.\"},{\"question\":\"What key patterns were observed for mortality risk?\",\"answer\":\"Women with blood Se in the lowest quartile (Q1) showed higher all-cause mortality risk, with the effect being stronger in HRG non-TT carriers than in HRG TT carriers.\"}]","All-Cause Mortality and Cancer Risk Dependent on Blood Se Level and HRG rs10770 Genotypes on a Prospective Cohort of Women with Familial Breast Cancers | PDF",1790086507,48,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cf5a60b16eb38c2853519d1de8db252e.webp",983,1390,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4ad20591cab880d8362dcd4dfe7648e9.webp",982,1388,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/33f47f34f039eceba4c3b0a81602ada3.webp",981,1387,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9354367d01f5ef2b509fcf33fa082832.webp",980,692]